Search research articles
Contact Us
Filters
Showing results (161-170 of 203) with videos related to
Page
of 21
Sort By:
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0
Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Kidney Cancer (Clifton, Va.)
|
July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
Albert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
The Oncologist
|
August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.
Clinical Genitourinary Cancer
|
January 13, 2026
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with Immunotherapy
Abby L Grier, Albert Jang, Jeffrey Y Zhong, et al.
International Journal of Molecular Sciences
|
June 26, 2025
<i>HSD3B1</i> (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers
Nikitha Vobugari, Allison Makovec, Samuel Kellen, et al.
Targeted Oncology
|
September 30, 2018
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
Alice Tzeng, C Marcela Diaz-Montero, Patricia A Rayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
Catherine H Marshall, Wei Fu, Hao Wang, et al.
JAMA Network Open
|
August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
The Prostate
|
April 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide
Albert Jang, Sree M Lanka, Minqi Huang, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 203) with videos related to
Sort By:
Page
of 21
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0
Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Kidney Cancer (Clifton, Va.)
|
July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
Albert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
The Oncologist
|
August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.
Clinical Genitourinary Cancer
|
January 13, 2026
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with Immunotherapy
Abby L Grier, Albert Jang, Jeffrey Y Zhong, et al.
International Journal of Molecular Sciences
|
June 26, 2025
<i>HSD3B1</i> (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers
Nikitha Vobugari, Allison Makovec, Samuel Kellen, et al.
Targeted Oncology
|
September 30, 2018
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
Alice Tzeng, C Marcela Diaz-Montero, Patricia A Rayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
Catherine H Marshall, Wei Fu, Hao Wang, et al.
JAMA Network Open
|
August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
The Prostate
|
April 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide
Albert Jang, Sree M Lanka, Minqi Huang, et al.
Page
of 21